Cities across the nation are organizing Moving Day as part of a community awareness program initiated by the National Parkinson’s Foundation. Movement is a symbol of hope and progress because of its essential role in treating Parkinson’s. Many people have a loved one or know someone afflicted with Parkinson’s disease. Statistics show that, to date, 1 million people have been diagnosed with Parkinson’s in the US, and more than 5 million diagnosed worldwide, with the number of new diagnoses expected to dramatically increase each year with our aging population. This is of great concern because there is still no disease modifying therapy available to treat the cause of Parkinson’s or delay disease progression, only drugs that treat the symptoms. The standard therapies, such as levodopa/carbidopa, have limitations and side effects, while newer drugs such as dopamine agonists, monoamine oxidase (MAO)inhibitors, and catechol-o-methyltransferase (COMT) inhibitors, have not proven as efficacious as originally anticipated.
So what is the outlook for the future of Parkinson’s? The following report will provide insight into the current clinical development landscape, which offers hope for potential new therapies in the near future and beyond.
One million people have been diagnosed with Parkinson’s in the US, and more than 5 million diagnosed worldwide, with the number of new
diagnoses expected to dramatically increase each year with our aging population. This paper is an informative discussion about the outlook for treatments and potential new therapies for Parkinson’s.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: